Page last updated: 2024-11-01

omeprazole and Granulocytic Leukemia, Chronic

omeprazole has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arranz, R1
Yañez, E1
Franceschi, JL1
Fernández-Rañada, JM1

Other Studies

1 other study available for omeprazole and Granulocytic Leukemia, Chronic

ArticleYear
More about omeprazole-cyclosporine interaction.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:1

    Topics: Adult; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Posi

1993